亚太传统医药2026，Vol.22Issue(4)：99-102,4.DOI:10.11954/ytctyy.202604019
潘立群教授运用伏邪理论治疗粉刺性乳痈经验
Professor Pan Liqun's Experience in Using"Latent Pathogen"Theory to Treat Acne Mastitis
摘要
Abstract
Acne mastitis is a non-inflammatory breast condition of unclear pathogenesis,typically characterized by breast lumps or recurrent abscess formation.The disease has a prolonged course and is difficult to cure,with limited ef-fectiveness of modern medicine treatment.With extensive experience in both basic and clinical research on breast disea-ses,he has developed significant expertise in treating acne mastitis.He has proposed that"although plasma cell mastitis is tangible and visible,it is,in essence,an invisible struggle between vitality and evil".Through long-term clinical prac-tice,Professor Pan Liqun has summarized and condensed the key features and therapeutic advantages of the"Tou method"for treating acne mastitis,grounding his approach in the traditional Chinese medicine(TCM)concept of the"Latent Pathogen"theory.The"Tou method"is applied according to the clinical presentation and follow the principle that"Dispering is most valuable"in TCM surgery during the stages of ulceration and lump formation,with an empha-sis on"Tou and Dispering".In the abscess stage,the focus shifts to clearing heat and detoxifying,emphasizing the re-moval of internal toxins before external drainage.Emphasis should be placed on clearing toxins and pus.During the re-covery period,therapeutic measures should support vital Qi,promote detoxification,and apply the principle of"Tou Promoting"-adapting to the pathogenesis,responding to clinical presentation,minimizing trauma,and preserving the natural appearance of the breasts.The approach has demonstrated significant clinical efficacy,and the following is pres-ented as a reference for clinical practice.关键词
粉刺性乳痈/透法/名医经验/伏邪理论Key words
Acne Mastitis/Tou Method/Experience of Famous Doctors/Latent Pathogen Theory分类
医药卫生引用本文复制引用
马丙娥,费宗奇..潘立群教授运用伏邪理论治疗粉刺性乳痈经验[J].亚太传统医药,2026,22(4):99-102,4.基金项目
第七批全国老中医药专家学术经验继承工作项目(国中医药人教函[2022]76号) （国中医药人教函[2022]76号）
江苏省中医药研究院自然科学基金(2024YZRKXJJ02) （2024YZRKXJJ02）
